| Name | ent-7β,14α-Dihydroxy-16-kauren-3,15-dione |
|---|---|
| Synonyms |
ent-7,14-Dihydroxy-16-kauren-3,15-dione
Glaucocalyxin A (5β,7α,8α,9β,10α,13α,14R)-7,14-Dihydroxykaur-16-ene-3,15-dione |
| Description | Glaucocalyxin A, an ent-kauranoid diterpene from Rabdosia japonica var., induces apoptosis in osteosarcoma by inhibiting nuclear translocation of Five-zinc finger Glis 1 (GLI1) via regulating PI3K/Akt signaling pathway. Glaucocalyxin A has antitumor effect[1]. |
|---|---|
| Related Catalog | |
| Target |
PI3K Akt |
| In Vitro | Glaucocalyxin A induces apoptosis by mitochondrial apoptotic pathway through several steps including increasing the Bax/Bcl-2 ratio, triggering the intracellular reactive oxygen species (ROS) generation, reducing mitochondrial membrane potential (MMP), and inducing cleavage of caspase-9 and caspase-3[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 513.4±50.0 °C at 760 mmHg |
| Melting Point | 219.5-220.5℃ |
| Molecular Formula | C20H28O4 |
| Molecular Weight | 332.434 |
| Flash Point | 278.4±26.6 °C |
| Exact Mass | 332.198761 |
| PSA | 74.60000 |
| LogP | 0.88 |
| Vapour Pressure | 0.0±3.0 mmHg at 25°C |
| Index of Refraction | 1.574 |
| Storage condition | 2-8°C |